Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(3.42)
# 795
Out of 4,818 analysts
27
Total ratings
58.33%
Success rate
14.73%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYEN Eyenovia | Downgrades: Neutral | n/a | $1.09 | - | 1 | Nov 18, 2024 | |
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $292.82 | +17.48% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $10.05 | +432.34% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $37.99 | +5.29% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $13.49 | +122.39% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $4.81 | +76.72% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $8.27 | +93.47% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $2.94 | +36,328.57% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $17 → $23 | $0.23 | +9,904.35% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $3.01 | +1,594.35% | 1 | Dec 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $4.34 | +268.66% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $3.94 | +1,042.13% | 1 | Jan 22, 2020 |
Eyenovia
Nov 18, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.09
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $292.82
Upside: +17.48%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $10.05
Upside: +432.34%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $37.99
Upside: +5.29%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $13.49
Upside: +122.39%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $4.81
Upside: +76.72%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $8.27
Upside: +93.47%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $2.94
Upside: +36,328.57%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $17 → $23
Current: $0.23
Upside: +9,904.35%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $3.01
Upside: +1,594.35%
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $4.34
Upside: +268.66%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $3.94
Upside: +1,042.13%